News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
362,701 Results
Type
Article (14410)
Company Profile (116)
Press Release (348175)
Section
Business (112609)
Career Advice (456)
Deals (18609)
Drug Delivery (28)
Drug Development (31162)
Employer Resources (49)
FDA (8790)
Job Trends (7670)
News (172716)
Policy (12353)
Tag
Academia (1318)
Alliances (34749)
Alzheimer's disease (485)
Approvals (8797)
Artificial intelligence (208)
Bankruptcy (130)
Best Places to Work (6522)
Biotechnology (87)
Breast cancer (100)
Cancer (847)
Career advice (406)
CAR-T (89)
Cell therapy (237)
Clinical research (24297)
Collaboration (510)
Compensation (89)
COVID-19 (1139)
C-suite (104)
Data (785)
Diabetes (82)
Diagnostics (4872)
Earnings (38293)
Events (50880)
Executive appointments (329)
FDA (9272)
Funding (403)
Gene editing (71)
Gene therapy (149)
GLP-1 (211)
Government (1229)
Healthcare (9879)
Infectious disease (1205)
IPO (7990)
Job creations (1434)
Job search strategy (362)
Layoffs (114)
Legal (2518)
Lung cancer (104)
Manufacturing (150)
Medical device (11415)
Medtech (11420)
Mergers & acquisitions (10888)
Metabolic disorders (181)
Neuroscience (641)
NextGen: Class of 2025 (3534)
Non-profit (1519)
Northern California (932)
Obesity (79)
Opinion (75)
Patents (109)
People (32560)
Phase I (8974)
Phase II (10967)
Phase III (7106)
Pipeline (361)
Postmarket research (501)
Preclinical (4031)
Press Release (66)
Radiopharmaceuticals (153)
Rare diseases (123)
Real estate (3356)
Regulatory (9262)
Research institute (1267)
Resumes & cover letters (68)
Series A (74)
Southern California (998)
Startups (2504)
United States (9795)
Vaccines (287)
Date
Today (37)
Last 7 days (402)
Last 30 days (1366)
Last 365 days (18159)
2025 (2832)
2024 (18711)
2023 (22098)
2022 (30813)
2021 (32512)
2020 (30537)
2019 (25793)
2018 (19458)
2017 (18871)
2016 (17761)
2015 (20560)
2014 (15177)
2013 (12742)
2012 (13781)
2011 (14066)
2010 (12826)
Location
Africa (318)
Arizona (110)
Asia (23899)
Australia (4161)
California (2422)
Canada (927)
China (197)
Colorado (143)
Connecticut (117)
Europe (48824)
Florida (395)
Georgia (115)
Illinois (246)
Indiana (139)
Japan (87)
Kansas (78)
Maryland (401)
Massachusetts (1704)
Michigan (172)
Minnesota (221)
New Jersey (760)
New York (710)
North Carolina (475)
Northern California (932)
Ohio (91)
Pennsylvania (495)
South America (504)
Southern California (998)
Texas (382)
Utah (90)
Washington State (288)
362,701 Results for "tikcro technologies".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Tikcro Technologies Announces Liquidating Dividend - February 09, 2023
Tikcro Technologies Ltd. announced the declaration of a liquidating cash dividend in the aggregate amount of $3,017,270, or $0.305 per share, without interest and subject to applicable withholding requirements.
February 9, 2023
·
2 min read
Tikcro Technologies Announces Extension of Submission Deadline regarding Liquidating Dividend
Tikcro Technologies Ltd. announced the extension of the deadline for the submission of documentation with respect to exemption from Israeli withholding in connection with its liquidating dividend, from April 10, 2023 to April 28, 2023, in order to enable additional shareholders to perfect exemptions prior to the dividend payment.
April 3, 2023
·
2 min read
Interim Report of Liquidation Trustee of Tikcro Technologies
Tikcro Technologies Ltd. (in liquidation) (OTC: TIKRF) today announced that the liquidation trustee has substantially completed the process of winding down the affairs of the Company.
July 25, 2022
·
1 min read
Tikcro Technologies to Proceed to Distribute Net Cash to Shareholders
Tikcro Technologies Ltd. (OTC: TIKRF) today announced that its Board of Directors has decided to take steps required to distribute the company’s net cash to its shareholders.
March 22, 2021
·
2 min read
Business
Tikcro Technologies Reports Third Quarter 2020 Results
Tikcro Technologies Ltd. (OTCQB: TIKRF), today reported its financial results for the third quarter ended September 30, 2020 . “We continue to consider businesses for a reverse merger and other corporate alternatives,” said Aviv Boim , CEO of Tikcro. Financial Results for the Third Quarter Ended September 30, 2020 N
January 14, 2021
·
2 min read
Business
Tikcro Technologies Reports Second Quarter 2020 Results
Tikcro Technologies Ltd. (OTCQB: TIKRF) today reported its financial results for the second quarter ended June 30, 2020.
October 30, 2020
·
2 min read
Tikcro Technologies Announces Extraordinary General Meeting - Mar 29, 2021
Tikcro Technologies Ltd. announced that an Extraordinary General Meeting of Shareholders will be held on Thursday, April 29, 2021 at 9:30 a.m., at the office of Goldfarb Seligman & Co., 98 Yigal Alon Street, Tel Aviv, Israel.
March 29, 2021
·
1 min read
Tikcro Technologies Announces 2020 Annual General Meeting
Tikcro Technologies Ltd. (OTCQB: TIKRF) today announced that its 2020 Annual General Meeting of Shareholders will be held on Thursday, December 31, 2020 at 9:00 a.m. (Israel time), at the office of Goldfarb Seligman & Co., 98 Yigal Alon Street, Tel Aviv, Israel.
November 25, 2020
·
1 min read
Press Releases
Silq Technologies Corp. and NuSil Technology LLC Announce Collaboration Agreement to Drive Broad-based Adoption of Silq’s Novel Surface Treatment Technology
February 19, 2025
·
3 min read
Artificial intelligence
FDA’s New AI Guidance Highlights Risks of Technology, Urges Early Sponsor Engagement
The FDA’s guidance on AI in drug development points to potentially life-threatening consequences of the technology, highlighting the importance of providing the regulator with detailed information regarding models’ development and maintenance.
January 7, 2025
·
2 min read
·
Tristan Manalac
1 of 36,271
Next